Pharmacom Prim 100 10 ml
Manufacturer: Pharmacom Labs.
Substance: Methenolone Enanthate.
Package: 10ml vial (100 mg/ml).
PHARMA PRIM 100 (Methenolone Enanthate) is a moderate anabolic but very low androgenic steroid that is incredibly versatile. It is often stacked with other (typically stronger) steroids in order to obtain a faster and more enhanced effect. PHARMA PRIM 100 will be suitable during both cutting cycles and bulk cycles; in both cases it will be responsible for the faster recovery and growth of lean and dense muscle mass.
Methenolone (also known as primobolan) was described in 1960. Squibb Company began producing injectable drug in 1962. Methenolone originally was prescribed in case of muscle loss after operations, infections, long-term illnesses, aggressive therapy with corticoids or malnutrition, and in some cases it was used to treat osteoporosis and breast cancer. Methenolone was commonly used to promote weight gain in infants, weighing less than normal, without any side effects. Methenolone is an anabolic steroid, modification of dihydrotestosterone (DHT) with weak androgenic activity and a moderate anabolic effect.
A notable trait of methenolone is that it can firmly bind to androgen receptors, stronger than testosterone. This trait makes primobolan to be a good fat burner.
Primobolan does not convert into estradiol; thereby you can take it without the risk of developing estrogenic side effects (gynecomastia, water retention).
Methenolone is one of most safe steroids on the market, hence women, elderly athletes and youth often find this steroid the best one to improve their physique and avoid side effects.
Overall, methenolone being one of the safest anabolic steroids available on the market is at the same time a rather weak compound and needs time to show affects at its best. Results of primobolan will be seen, if the drug is used at least 10 weeks and in stack with other steroids. Primobolan is well suited for cutting cycles when a mass gain is not the main goal.
Dosage men 300 - 800 mg / week.